b.value AG

bvalue.de

VCMatch tracks b.value AG as an investor focused on Biotech, Climate/Cleantech, and Hardware companies, Pre-Seed and Seed rounds, and Germany, Austria, and Switzerland markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Pre-Seed, Seed

Focus Areas

Biotech, Climate/Cleantech, Hardware

Geography

Germany, Austria, and Switzerland

Investment Thesis

b.value AG invests in DeepTech startups that combine exceptional founding talent with disruptive technologies to create solutions for a sustainable future. They believe sustainable processes and products form the foundation for tomorrow’s world. Their approach is based on deep technology expertise and extensive operational experience in building and managing biotech and high-tech companies, enabling them to identify and support the most promising startups to realize their full potential.

Is b.value AG right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

b.value AG is most relevant for founders raising Pre-Seed and Seed rounds in Biotech, Climate/Cleantech, Hardware, and Data Infrastructure, especially across Germany, Austria, and Switzerland.

Focus statement

b.value invests in DeepTech startups in biotechnology (including precision fermentation, sustainable chemicals, food/feed, life science methods) and advanced materials sectors, focusing on pre-seed and seed-stage companies in the European D-A-CH region.

Value Add

Unique 'b.value Company Building' approach providing active operational support beyond capital
Team of PhD-level scientists with deep technology understanding enabling assessment 'under the hood'
25+ years of combined entrepreneurial experience in building and scaling biotech/high-tech companies
Extensive network including industry experts, scientists, investors, policy makers, and academic thought leaders
Flexible and long-term oriented investment structure allowing for both early-stage seed investments and secondary share acquisitions
Focus on co-investment model to minimize risks and bundle resources
Unique access in Germany to participate in future biotech and materials companies at very early development stages